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Background/Aims
High-resolution manometry (HRM) with pressure topography is used to subtype achalasia cardia, which has therapeutic im-
plications. The aim of this study was to compare the clinical characteristics, manometric variables and treatment outcomes 
among the achalasia subtypes based on the HRM findings.
Methods
The patients who underwent HRM at the Asian Institute of Gastroenterology, Hyderabad between January 2008 and January 
2009 were enrolled. The patients with achalasia were categorized into 3 subtypes: type I - achalasia with minimum esophageal 
pressurization, type II - achalasia with esophageal compression and type III - achalasia with spasm. The clinical and mano-
metric variables and treatment outcomes were compared.
Results
Eighty-nine out of the 900 patients who underwent HRM were diagnosed as achalasia cardia. Fifty-one patients with a mini-
mum follow-up period of 6 months were included. Types I and II achalasia were diagnosed in 24 patients each and 3 patients 
were diagnosed as type III achalasia. Dysphagia and regurgitation were the main presenting symptoms in patients with types 
I and II achalasia. Patients with type III achalasia had high basal lower esophageal sphincter pressure and maximal esophageal 
pressurization when compared to types I and II. Most patients underwent pneumatic dilatation (type I, 22/24; type II, 20/24; 
type III, 3/3). Patients with type II had the best response to pneumatic dilatation (18/20, 90.0%) compared to types I (14/22, 
63.3%) and III (1/3, 33.3%).
Conclusions
The type II achalasia cardia showed the best response to pneumatic dilatation.
(J Neurogastroenterol Motil 2011;17:48-53)
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Introduction
Achalasia cardia is a motility disorder of the esophagus with 
an estimated prevalence of 0.5-1.0/100,000 population per year. 
It is characterized by dysphagia for solids and liquids. The other 
features include regurgitation of undigested food, chest pain, 
weight loss and respiratory symptoms.
1,2 Incomplete relaxation of 
lower esophageal sphincter (LES) on swallowing, absence of eso-
phageal peristalsis and elevated basal LES pressures
1,2 are the fi-
ndings on esophageal manometry of achalasia cardia. High-reso-
lution manometry (HRM) is replacing conventional pull throu-
gh manometry as it is more sensitive and easier to perform and 
analyze.
3-5 HRM provides detailed pressure topography of the 
esophagus and allows a better identification of compartmental-
ized distal esophageal pressurization than conventional manome-
try.
6-9 HRM with pressure topography is being used to classify 
achalasia into different subtypes.
10,11
The treatment modalities for achalasia cardia include drug 
therapy, endoscopic pneumatic dilatation, endoscopic botulinum 
injection and surgery. The predictors of therapeutic failure for 
endoscopic pneumatic dilatation are younger age (40-45 years), 
male, dilated oesophagus, use of a small sized balloon (30 mm), 
repeated dilatations and a post dilatation LES pressure > 10 
mmHg.
12-14 The subtypes of achalasia cardia show variable re-
sponse to endoscopic pneumatic dilatation. This variation in ther-
apeutic outcome with pneumatic dilatation would allow us to cat-
egorize patients into different subgroups. The aim of this study 
was to compare the clinical characteristics, manometric variables 
and treatment outcomes within the subtypes of achalasia cardia 
based on the HRM findings. This is the first study in the Indian 
population.
Materials and Methods
The study was conducted at the Asian Institute of Gastroen-
terology, Hyderabad between January 2008 and January 2009. 
The patients underwent HRM and found to have impaired LES 
relaxation were further analyzed. They underwent an upper gas-
trointestinal endoscopy to rule out secondary achalasia. The study 
protocol was approved by the Asian Institute of Gastroenterology 
Institutional Review Board. The inclusion and exclusion criteria 
were as follows: patients of any age presenting to the outpatient 
department or referred for esophageal manometry and diagnosed 
as achalasia cardia were included. Patients were excluded with the 
followings: (1) previous treatment for achalasia cardia, (2) pa-
tients with esophageal lesions such as webs, rings, strictures or 
malignancy of esophagus or stomach, (3) previous history of eso-
phageal or gastric surgeries and (4) history of nasal surgery dur-
ing the last 6 months. 
Manometry was performed with a 16 channel water perfused 
catheter which has 8 channels 1 cm apart at the lower end and the 
remaining 8 channels 3 cm apart (Dent sleeve International Li-
mited, manufactured by Mui scientific, Ontario, Canada). The 
data were analyzed using Trace 1.2 V software (Geoff Hebbard, 
Royal Melbourne Hospital, Victoria, Australia). The manometry 
catheter was introduced by the transnasal route. The protocol in-
cluded a basal LES pressure recording for 3 minutes, followed by 
ten 5 mL wet swallows with an interval of 30 seconds between 
each of the swallows.
Each of the 10 wet swallow frames included: upper esoph-
ageal sphincter relaxation, esophageal body contraction and LES 
relaxation. The esophageal body contraction was clearly visua-
lized by the isobaric colour contour plot, which provided a con-
tinuous depiction of pressure along the entire recording segment. 
This allowed for a complete spatial and temporal analysis of eso-
phageal motor events. 
Achalasia was diagnosed as an impaired LES relaxation on 
deglutition (mean integrated relaxation pressure ≥ 15 mmHg) 
and aperistalsis of the esophageal body. The integrated relaxation 
pressure was defined as the LES relaxation pressure for 4 sec-
onds within the relaxation window. Integrated relaxation pressure 
can be contiguous or non-contiguous and is usually less than 15 
mmHg.
11
The patients with impaired LES relaxation were divided into 
3 subtypes based on the dominant feature of the distal esophageal 
pressure after swallowing.
10,11 Clinical, manometric variables and 
treatment outcomes were compared among the 3 subtypes. For 
type I achalasia (classic achalasia), the distal esophageal pressure 
was less than 30 mmHg in more than 8 out of the 10 wet swallows 
(Figure A). For type II achalasia (achalasia with esophageal com-
pression), at least 2 out of the 10 wet swallows were associated 
with a pan esophageal pressurization greater than 30 mmHg (Fig-
ure B). For type III achalasia (spastic achalasia), there were 2 or 
more spastic contractions (contractile front velocity [CFV] > 8 
cm/s)
11 with or without periods of compartmentalized pressuriza-
tion (Figure C). The CFV was calculated from the slope of the 
line connecting the 30 mmHg isobaric contour at the proximal 
margin of S2 and the distal margin of the S3. Endoscopic pneu-
matic dilatation was performed using a Rigiflex balloon with a 35 Nitesh Pratap, et al
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Figure. Achalasia subtypes. (A) Type I (classic achalasia), there is no 
significant pressurization within the body of the esophagus. (B) Type II 
(achalasia with compression), there is rapid pan-esophageal pressuriza-
tion. (c) Type III (spastic achalasia), this swallow shows spastic contrac-
tion.
mm diameter (Microvasive). The balloon was placed over an en-
doscopically introduced guide wire and positioned across the LES. 
After confirmation of the position by fluoroscopy, the balloon was 
left inflated for 1 minute. The need for further dilatation was de-
termined by the persistence of symptoms 4 weeks after treatment. 
The patients were followed for 6 months after endoscopic pneu-
matic dilatation. A successful treatment response was defined as 
symptomatic relief requiring no further intervention up to 6 mon-
ths after a single intervention.
13
Statistical Methods
The clinical and manometric parameters were summarized 
using mean ± SD. The data was analyzed by Statistical Package 
for Social Sciences (SPSS) 13.0 version (SPSS Inc, Chicago, IL, 
USA). The Chi-square test was used to compare the categorical 
variables among the subtypes. The comparison among the 3 sub-
types for normal continuous data was performed using a one way 
analysis of variance. The comparison among the 3 subtypes for 
abnormal continuous data was performed using the Kruskal- 
Wallis test. The comparison between 2 subtypes was performed 
using the t test for normal continuous data and the Wilcox Rank 
Sum test for abnormal continuous data. The predictors of re-
sponse to pneumatic dilatation among the different subtypes were 
assessed using the multivariate logistic regression analysis. A 
P-value of less than 0.05 was considered statistically significant. 
For calculation of odds ratio, achalasia subtype I was considered 
as the control because it represented the classic definition of acha-
lasia cardia.
Results
Eighty-nine of the 900 patients who underwent HRM were 
diagnosed as achalasia cardia. Fifty-one patients with a mean fol-
low-up of 6 months were included in the study. Achalasia Subtyping Predicts Outcome
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Table 1. Clinical and Manometric Characteristics of the Achalasia Subtypes
Variables Type I (n = 24) Type II (n = 24) Type III (n = 3) P-value
Age (mean ± SD [yr])
    range
  38.04 ± 13.53
 19-70
 42.42 ± 15.16
16-70
41.00 ± 15.71
27-58
    0.577
Sex (male/female) 14/10 12/12 1/2     0.662
Dysphagia 24 24 2 < 0.001
Chest pain   7   7 3     0.041
Regurgitation 15 17 0     0.057
Basal LES pressure (mean ± SD)
    range
  29.33 ± 16.95
   4.70-74.90
 38.57 ± 11.57
24.10-65.89
59.86 ± 15.14
42.90-72.00
    0.002
Maximal esophageal pressurization (mean ± SD)
    range
13.29 ± 5.02
   5-20
 50.33 ± 16.65
10-78
76.66 ± 20.81
 60-100
< 0.001
LES, lower esophageal sphincter.
Table 2. Comparison of Clinical and Manometric Characteristics 
among the Subtypes of Achalasia
Variables
Type I vs II
(P-value)
Type I vs III
(P-value)
Type II vs III
(P-value)
Age (yr)     0.297     0.728 0.880
Sex (male/female)     0.562     0.569 1.000
Dysphagia       -     0.111 0.111
Chest pain     1.000     0.041 0.041
Regurgitation     0.540     0.075 0.041
Basal LES pressure     0.032     0.007 0.007
Maximal esophageal < 0.001 < 0.001 0.018
  pressurization
LES, lower esophageal sphincter.
Table 3. Predictors of Response to Pneumatic Dilatation
Variables OR (95% CI) P-value
Age (≤ 40 vs > 40 yr) 0.94 (0.86-1.02) 0.366
Male vs Female 4.17 (0.66-26.29) 0.344
Duration of symptoms 1.01 (0.97-1.05) 0.467
  (≤ 60 vs > 60 mo)
Type of achalasia 5.14 (0.94-28.14) 0.042
Achalasia Subtypes
Types I and II achalasia were observed in 24 patients each 
and type III achalasia in 3 patients. The mean age of patients be-
tween types II and III were similar, compared to type I with 
younger age (P = 0.577). The male to female ratio in all the 
groups were similar (P = 0.662). Dysphagia and regurgitation 
were more frequently presenting symptoms in types I and II (P
<0 . 0 0 1  a n d  P = 0.057, respectively) than type III. The patients 
with type III had a higher incidence of chest pain when compared 
to the others (P = 0.041) (Table 1).
An intergroup analysis was performed to investigate the dif-
ferences in terms of clinical variables and manometric parameters 
among the 3 subtypes (Table 2). The clinical variables were not 
significantly different among the 3 subgroups except chest pain 
in type III achalasia. However, the manometric parameters were 
different among the 3 subgroups. The patients with type III had 
spastic contraction in most of the swallows, and also had higher 
basal LES pressure and maximal esophageal pressurization when 
compared to types I and II (P < 0.001) (Table 1). For patients 
with type II achalasia, the swallows were associated with com-
pression while the patients with type I had failed swallows.
Clinical Outcomes
Endoscopic pneumatic dilatation was performed in 45 out of 
the 51 patients, endoscopic injection of botulinum neurotoxin in 
4, pharmacological treatment in 1 and Heller’s myotomy in 1 
respectively. Since the number of patients who underwent botu-
linum toxin injection and surgery were small, they were not in-
cluded in the clinical outcome analysis.
Data from 45 patients who had undergone endoscopic pneu-
matic dilatation was used to assess the treatment outcomes. A 
subgroup analysis was performed to investigate the differences in 
terms of clinical variables, manometric parameters and response 
to endoscopic pneumatic dilatation among the 3 subtypes. The 
response to pneumatic dilatation was best in type II (18/20, 90.0%) 
compared to type I (14/22, 63.0%) and type III (1/3, 33.3%). 
The other variables which have an influence on the response to 
endoscopic pneumatic dilatation were age, sex, and the duration 
of symptoms. Multivariate logistic regression analysis of response 
to endoscopic pneumatic dilatation with age, sex, the duration of 
symptoms and types of achalasia was performed (Table 3). Among Nitesh Pratap, et al
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these variables, the types of achalasia was found to have a sig-
nificant correlation with response to endoscopic pneumatic dilata-
tion (P = 0.042) (Table 3). The other variables were not statisti-
cally significant. According to data, patients with type II achalasia 
had the best response to endoscopic pneumatic dilatation: type II 
vs I (P = 0.045), type II vs III (P = 0.016) and type I vs III (P
= 0.315). The analysis of the odds ratio for patients with type II 
achalasia showed that they responded better to pneumatic dilata-
tion (OR, 5.14; 95% CI, 0.94-28.14) when compared to type I 
achalasia.
Discussion
This is the first manometric study of the Indian population to 
classify the subtypes of achalasia. The frequency of subtypes I 
and II was the same in the present study, different from the fi-
ndings reported by Pandolfino et al
10 where type II was more 
common.
Type I achalasia was more common in the younger age group 
with dysphagia and regurgitation as the main features. Type II 
achalasia had similar features to type I except age (Table 1).
The cause of chest pain, a common symptom associated with 
achalasia, remains unknown. Eckardt et al
15 studied chest pain in 
patients with achalasia and reported an association with a young-
er age and short duration of symptoms. However, there was no 
correlation with the manometric or radiographic findings. In our 
study, patients with type III achalasia had chest pain. The patho-
genesis of chest pain associated with type III achalasia may be re-
lated to the high esophageal pressurization. 
The rate of therapeutic failure is high in younger patients.
16 
Chuah et al
17 showed that older patients (> 45 years) had an 
overall favorable rate of clinical remission in a prospective 7-year 
follow-up study of endoscopic pneumatic dilatation. Ghoshal et 
al
18 in their study of therapeutic failure after pneumatic dilatation 
showed on multivariate analysis that male gender was associated 
with poor outcome. Age, grade of dysphagia, esophageal dilata-
tion and pre-dilatation LES pressure did not affect the out-
come.
18 In our study, response to pneumatic dilatation had no 
correlation with age (P = 0.366) and sex (P =0 . 3 4 4 ) .  
The major finding in our study was that HRM could pre-
dict the response to endoscopic pneumatic dilatation in achalasia. 
Type II achalasia was a strong positive predictor of response to 
endoscopic pneumatic dilatation and type III achalasia was a 
strong negative predictor. Patients with type II achalasia tended 
to have a less severe dilatation of esophagus compared to type I 
and might represent an early stage of the disease. Hence, they re-
sponded better to treatment. Patients with type I tended to have 
severe esophageal dilatation due to prolonged functional ob-
struction at the LES with minimal contractility of esophageal 
body and might represent a late stage in the natural history of 
achalasia. Patients with type II had preserved longitudinal muscle 
contraction and sufficient excitation of the circular muscle to gen-
erate substantial intrabolus pressure in the esophageal body. 
Thus, reduction of the LES pressure with therapy would give 
good response to these patients. 
In conclusion, this study presented the clinical and mano-
metric predictors for treatment response of achalasia and the clin-
ical usefulness of HRM. The results showed that the patients 
with type II achalasia responded better to endoscopic pneumatic 
dilatation compared to the others. The subtyping of achalasia by 
HRM may allow the clinician to direct therapy and predict out-
comes.
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